|
|
 |
|
Viewing report
|
|
 |
ArQule, Inc.
Sheila Greco Associates, May 2011, Pages: 1
ArQule, Inc. is a biotechnology company engaged in research and development of next-generation small-molecule cancer therapeutics based on its innovative Activated Checkpoint Therapy(SM) (ACT(SM)) platform. ACT(SM) compounds are intended to improve the wa
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
 |
|
|